Coagulation Question Notes (Book) Flashcards

1
Q

What is the treatment of choice for

congenital Factor VII deficiency ?

A
  • recombinant Factor VIIa
  • In the past FFP or Prothrombin complex concentrates were used
    • but since both are plasma derived there is risk of infection
    • large volumes of plasma are also needed to replace the factor, because it has a short half life
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the composition of

prothrombin complex concentrate?

A
  • Factors II, VII, IX and X
    • all vitamin K dependant
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is a potential complication of

treating patients with recombinant Factor VII for a while ?

A
  • they can develop autoantibodies to Factor VII which may cause the PT mix to remain long after mixing and complicate therapy
  • this should be considered if the patient stops responding to Factor VII
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the inheritance pattern of

Factor VII deficiency and clinical presentation ?

A
  • Autosomal recessive
  • affects males and females
  • > 250 gene mutations have been identified
  • IMP
    • in contrast to hemophilia A and hemophilia B, the level of factor VII in patients with congenital deficiency does not correlate well with the clinical severity of bleeding symptoms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

At what factor level would significant

bleeding in Factor VII deficiency be expected ?

A
  • if activity is <1%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are common types of bleeding

symptoms seen in Factor VII deficiency ?

A
  • easy bruising
  • epistaxis
  • soft tissue hemorrhage
  • menorrhagia
  • bleeding with trauma
  • postoperative bleeding

Note:

  • postpartum and intracranial hemorrhage may be seen in severely affected patients
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is something that is frequently seen

in patient’s with Factor VII deficiency ?

A
  • paradoxical thromboembolism
    • both arterial and venous
    • this would complicate measuring levels
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the characteristic presentation of hemophilia

in a newborn ?

A
  • circumcision bleeding

Note: Hemophilia A and B are indistinguishable clinically, but the majority of patients have Hemophilia B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the clinical differential diagnosis

for Hemophilia ?

A
  • defect in primary hemostsasis
    • vWD
    • disorder of platelet function
    • IMP:
      • disorders of primary hemostasis do not usually present with circumcision bleeding but rather with oral bleeding, epistaxis, and gastrointestinal bleeding
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is a particular issue when measure factor

levels in newborns ?

A
  • there may be normal mildly decreased factor levels
    • due to newborn liver
    • affects factors produced in liver (not Factor V)
    • this may lead to a mildly prolonged PT
    • a factor level of 30% may be normal for a newborn so do not overcall
      • levels around 1-5% are never normal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the appropriate management of

severe hemophilia ?

A
  • initiate factor replacement with VIII or IX
    • treatment must be continued until the bleeding stops
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

If there is a family history of hemophilia

when do pregnant women get tested ?

A
  • tested in the 8th month of pregnancy
    • this is to help with the delivery and obtain baby’s cord blood for testing
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the inheritance pattern

of Hemophilia A ?

A
  • for both Hemophilia A and B
    • sex-linked recessive
    • affect males with carrier females
    • A > B 4:1 ratio
  • up to 1/3 of hemophilia cases arise as spontaneous mutations
    • defective gene is on mother’s X chromosome
  • 1/2 of cases have a signature mutation
    • intron 22 inversion
    • easily can be assessed by PCR
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the accepted treatment of Hemophilia A ?

A
  • in order to prevent joint bleeding or damage
    • prophylactic infusions of Factor VIII (3x per week)

IMP: these children tend to develop autoantibodies to the infused Factor VIII and they become not responsive to treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the differential diagnosis for

decreased Factor VIII in a woman ?

A
  • Hemophilia A carrier
  • von Willebrand disease
  • both

Note: a woman may have hemophilia if she inherits two abnormal chromsomes (from mom and dad or if she has Turners)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the mechanism of action of

DDAVP and possible issue with it’s use in treating

Hemophilia A ?

A
  • DDAVP induces release of Factor VIII and vWF from endothelial cell Weibel-Palade bodies
  • problem:
    • with continued use of DDAVP the stores are depleted within 3 days so patients may bleed
    • need to treat ongoing bleeding with Factor VIII concentrates
17
Q

What sort of medications are

contraindicated in patients with bleeding disorders ?

A
  • drugs inhibiting platelet function (primary hemostasis)
  • vWD and Hemophilia are secondary hemostasis
18
Q

What is the differential diagnosis for

Hemophilia B ?

A
  • Factor VIII deficiency
  • Factor IX deficiency (hemophilia B)
  • von Willebrand disease
  • Congenital deficiency of Factor XI
19
Q

What can possibly be tried to

reduce an anti-Factor IX or VIII inhibitor?

A
  • trying larger doses of clotting factor to overwhelm the antibody or induce immune tolerance
    • especially by trying daily dosing of the recombinant factor
20
Q

How are Factor VIII and IX deficiencies graded ?

A
  • Severe: <1%
  • Moderate: 2-5%
  • Mild: >5%

Note: Hemophilia B is extremely common in the Amish community

21
Q

What clinical presentation is common in

Hemophilia A and B ?

A
  • LACK of menorrhagia
    • this type of bleeding is considered mucosal and more likely to be seen with platelet disorders and vWD
22
Q

For carrier patients of Hemophilia A and B, what

is the amount of time they must receive recombinant factor

in anticipation of surgery or delivery ?

A
  • 4 days of factor minimum
23
Q

When there is prolongation of both

PT and PTT what should be

suspected?

A
  • a common pathway issue
  • if there is no correction with mixing studies then an inhibitor should be suspected
  • Common pathway factors
    • II
    • V
    • X
    • can evaluated specific factors using direct assays for them
24
Q

What are available treatments for

common pathway inhibitors ?

A
  • general approach is immunosuppression
    • steroids, IVIG, and various chemotherapeutic agents
    • Rituximab could be considered in refractory cases
  • plasma transfusions
    • unlikely to overcome a high titer antibody
    • may result in fluid overload
  • anti-fibrinolytics
    • can control the bleeding
  • plasmapharesis
25
Q

What common scenario have factor V

inhibitors been described in ?

A
  • contaminated bovine thrombin used topically
    • leads to an acquired factor V inhibitor
  • factor V inhibitors are the second most common factor inhibitors
    • factor VIII is the most common